跳到正文
Prof. Dr. Ahmet Dirican· @dr_dirican · X·· 2 天前评分70

INTERPATH-001

正文 · 原文

Cancer vaccines take center stage at #ESMO26

Oct 23: mRNA cancer vaccines
Oct 24: INTERPATH-001 Phase III – personalized mRNA neoantigen therapy + pembrolizumab in melanoma
Oct 25: All about cancer vaccines

Eagerly awaiting the Phase III results!

#CancerVaccines #mRNA #ESMO2026 @myESMO

129 浏览 · 1 赞 · 1 转发 · 0 回复

会议摘要
LBA1按 Presidential Symposium I 对上

INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) intismeran autogene (intismeran) plus pembrolizumab (pembro) vs pembro alone for adjuvant treatment of resected stage IIB-IV melanoma (MEL)

https://esmocongress.esmo.org

来源:Prof. Dr. Ahmet Dirican · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org